Epigenomic Programming With Omega Therapeutics' Mahesh Karande
Business Of Biotech · 62 minutes ·

Epigenomic Programming With Omega Therapeutics' Mahesh Karande

Using computational biology to hasten the effort, Omega Therapeutics' plan  is to "coopt nature's universal biological operating system for gene control and cell differentiation."  On this episode of the Business of Biotech, we dig into exactly what that means. We also explore the company's preclinical ambitions, which are diverse, targeting regenerative, multigenic/immunologic, oncologic, and monogenic indications. Omega is leaning heavily into computational biology along the way, having mapped what CEO Mahesh Karande characterizes as 95% of the IGD landscape. Learn how Karande intends to maintain momentum on this episode of the Business of Biotech. 

Comments (0)

You Must Be Logged In To Comment

Similar podcasts

Mind Tap with Alternative Therapeutics

Omega Frequency

OMEGA MALE

Programming with Palermo

Omega Road Chronicles

Get With The Programming

Learn Programming With eduAlgo